Last 12 months
Inside the activity.
3 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2018 Filed Jun 26, 2018 18:27 UTC |
Mass Robert D.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0000899243-18-018106 · doc4.xml · derivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-06-22 F1 · derivative.exercise_date: One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 14:14 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 128,920 | $2.07 | $266,864.40 |
DisclosureSEC source: 0001209191-18-022186 · doc4.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,080 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on March 29, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying vested restricted stock units. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 18:12 UTC |
DRISCOLL FREDERICK WDirector
|
GrantOptions to purchase shares of common stock · Derivative | 33,333 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-18-013268 · doc4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock, par value $0.00000002 per share · 33,333 shares Expires 2028-02-22 F1 · derivative.exercise_date: 20,000 options will vest ratably each month beginning March 1, 2018 over thirty-six months, and 13,333 of the options will vest ratably each month beginning March 1, 2018 over four months. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 23:39 UTC |
Baltic Charles V. IIIDirector
|
PurchaseCommon Stock, par value $0.00000002 | 11,000 | $2.25 | $24,800.60 |
DisclosureSEC source: 0000899243-17-027566 · doc4.xml · nonDerivative · entry 2 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,250 F2 · kind: The shares purchased by the reporting person are held through a brokerage account. Offsetting purchases and sales were conducted by the reporting person, with the purchase price exceeding the sales price, at no profit to the reporting person, for tax planning purposes. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 23:39 UTC |
Baltic Charles V. IIIDirector
|
SaleCommon Stock, par value $0.00000002 | 11,000 | $2.21 | $24,271.50 |
DisclosureSEC source: 0000899243-17-027566 · doc4.xml · nonDerivative · entry 1 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 F1 · kind: The shares sold by the reporting person are held through an Individual Retirement Account. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 14:29 UTC |
Urso David MSr. V.P. and General Counsel
|
GrantOption to purchase shares of common stock · Derivative | 130,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044523 · doc4.xml · derivative · entry 1 Urso David M · CIK 0001604256 · Sr. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,500 Underlying: Common Stock par value $0.00000002 · 130,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 14:24 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantOption to purchase shares of common stock · Derivative | 380,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044519 · doc4.xml · derivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234,166 Underlying: Common Stock par value $0.00000002 · 380,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months. F2 · balance_after: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:56 UTC |
White Christine AnnaDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044536 · doc4.xml · derivative · entry 1 White Christine Anna · CIK 0001371859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,730 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. F2 · balance_after: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:35 UTC |
Rueckert William DodgeDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044533 · doc4.xml · derivative · entry 1 Rueckert William Dodge · CIK 0001380016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,730 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. F2 · balance_after: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:34 UTC |
Reynolds Thomas CDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044531 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,049 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:33 UTC |
Glover NicholasDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044529 · doc4.xml · derivative · entry 1 Glover Nicholas · CIK 0001578888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,793 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:32 UTC |
Clemens KevanDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044527 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,667 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:31 UTC |
Baltic Charles V. IIIDirector
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044525 · doc4.xml · derivative · entry 1 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,730 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. F2 · balance_after: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:22 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantOption to purchase shares of common stock · Derivative | 50,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044517 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock par value $0.00000002 · 50,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:27 UTC |
Mass Robert D.Chief Medical Officer
|
GrantOption to purchase shares of common stock · Derivative | 135,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044521 · doc4.xml · derivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,556 Underlying: Common Stock par value $0.00000002 · 135,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months. F2 · balance_after: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:55 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantOption to purchase shares of common stock · Derivative | 150,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-17-025201 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock par value $0.00000002 · 150,000 shares Expires 2027-04-03 F1 · derivative.exercise_date: One-quarter of the options will vest on April 3, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.